These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9814610)

  • 1. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.
    Wood D; De Backer G; Faergeman O; Graham I; Mancia G; Pyörälä K
    J Hypertens; 1998 Oct; 16(10):1407-14. PubMed ID: 9814610
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention.
    Eur Heart J; 1998 Oct; 19(10):1434-503. PubMed ID: 9820987
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.
    Wood D; De Backer G; Faergeman O; Graham I; Mancia G; Pyörälä K
    Atherosclerosis; 1998 Oct; 140(2):199-270. PubMed ID: 9862269
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)].
    de Backer G; Graham I; Poole-Wilson P; Pyörälä K; Shepherd J; Wood D; Zanchetti A
    Rev Esp Cardiol; 1995 Dec; 48(12):773-80. PubMed ID: 8685497
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.
    Wood D; De Backer G; Faergeman O; Graham I; Mancia G; Pyörälä K
    Blood Press; 1998 Nov; 7(5-6):262-9. PubMed ID: 10321437
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
    EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
    Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A symposium: lipid management summit on improving practice outcome. Introduction.
    Ballantyne CM
    Am J Cardiol; 2000 Feb; 85(3A):1A-2A. PubMed ID: 10695700
    [No Abstract]   [Full Text] [Related]  

  • 8. New British recommendations for prevention of coronary heart disease in clinical practice.
    Faergeman O
    Heart; 1999 Apr; 81(4):335. PubMed ID: 10092555
    [No Abstract]   [Full Text] [Related]  

  • 9. Royal College of Physicians of Edinburgh Consensus Conference on lipid lowering to prevent vascular events 17 & 18 March 1999.
    Scott Med J; 1999 Jun; 44(3):73-4. PubMed ID: 10461692
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diabetes mellitus and coronary artery disease. Update on diagnosis and drug therapy].
    Marx N; Blessing E
    Dtsch Med Wochenschr; 2007 May; 132(19):1034-8. PubMed ID: 17476633
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
    Pyörälä K; De Backer G; Graham I; Poole-Wilson P; Wood D
    Eur Heart J; 1994 Oct; 15(10):1300-31. PubMed ID: 7821306
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
    Pyörälä K; De Backer G; Graham I; Poole-Wilson P; Wood D
    Atherosclerosis; 1994 Oct; 110(2):121-61. PubMed ID: 7848365
    [No Abstract]   [Full Text] [Related]  

  • 13. The future of coronary heart disease prevention.
    Warren J
    Clin Med (Lond); 2007 Oct; 7(5):524-5; author reply 525-6. PubMed ID: 17992766
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyörälä K; de Backer G; Graham I; Poole-Wilson P; Wood D
    Arch Mal Coeur Vaiss; 1995 Oct; 88(10 Suppl):1493-542. PubMed ID: 8815824
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholesterol lowering as a treatment for established coronary heart disease.
    LaRosa JC; Cleeman JI
    Circulation; 1992 Mar; 85(3):1229-35. PubMed ID: 1346980
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipids and prevention in coronary care.
    Betteridge DJ
    Trans Med Soc Lond; 1994-1995; 111():43-58. PubMed ID: 9156156
    [No Abstract]   [Full Text] [Related]  

  • 17. [The prevention of coronary disease in clinical practice. The recommendations of the Second Joint Task Force of European Societies on the Prevention of Coronary Pathology. Società Europea di Cardiologia, Società Europea dell'Aterosclerosi, Società Europea dell'Ipertensione].
    Wood D; De Backer G; Faergeman O; Graham I; Mancia G; Pyörälä K
    Ital Heart J Suppl; 2000 May; 1(5):692-8. PubMed ID: 10834137
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of coronary disease in clinical practice. Guidelines of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyorala K; De Backer G; Graham I; Poole-wilson P; Wood D
    G Ital Cardiol; 1996 Feb; 26(2):127-68. PubMed ID: 8666173
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations.
    Sacks FM;
    Am J Cardiol; 2002 Jul; 90(2):139-43. PubMed ID: 12106843
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of hyperlipidaemia. Why, when and how to treat.
    Oliver MF; Pyörälä K; Shepherd J
    Eur Heart J; 1997 Mar; 18(3):371-5. PubMed ID: 9076374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.